Liangbo Sun

Years Active: 2024-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Liangbo Sun, Meng He, Feng Li, Di Wu, Ping Zheng, Cong Zhang, Yang Liu, Dong Liu, Meihua Shan, Mingzhen Yang, Yuanhang Ma, Jiqin Lian, Haojun Xiong
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology communications 8 (4) (2024)
Liangbo Sun, Meng He, Feng Li, Di Wu, Ping Zheng, Cong Zhang, Yang Liu, Dong Liu, Meihua Shan, Mingzhen Yang, Yuanhang Ma, Jiqin Lian, Haojun Xiong
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology communications 8 (4) (2024)
Liangbo Sun, Meng He, Feng Li, Di Wu, Ping Zheng, Cong Zhang, Yang Liu, Dong Liu, Meihua Shan, Mingzhen Yang, Yuanhang Ma, Jiqin Lian, Haojun Xiong
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology communications 8 (4) (2024)
Liangbo Sun, Meng He, Feng Li, Di Wu, Ping Zheng, Cong Zhang, Yang Liu, Dong Liu, Meihua Shan, Mingzhen Yang, Yuanhang Ma, Jiqin Lian, Haojun Xiong
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatology communications 8 (4) (2024)

Liangbo Sun.css-eqlu8i{font-size:small;padding-left:4px;}